MWG Biotech Inc. Purchases Second Genome Sequencer FLX System to Expand Capacities in Line with Growing Sequencing Demand

Published: Apr 15, 2008

BRANFORD, Conn.--(BUSINESS WIRE)--454 Life Sciences, a centre of excellence of Roche Applied Science, today announced that MWG Biotech, a European market leader in genome sequencing services, is further expanding its 454 Sequencing capacity in order to meet the demands of a steadily increasing number of sequencing customers across Europe.

Back to news